Table of Contents Author Guidelines Submit a Manuscript
International Journal of Vascular Medicine
Volume 2012, Article ID 508416, 9 pages
Review Article

Role of Peroxisome Proliferator-Activated Receptor-γ in Vascular Inflammation

Department of Molecular Cardiovascular Biology and Pharmacology, Graduate School of Medicine, Ehime University, Shitsukawa, Ehime, Toon 791-0295, Japan

Received 6 May 2012; Accepted 8 June 2012

Academic Editor: David Bishop-Bailey

Copyright © 2012 Kousei Ohshima et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [15 citations]

The following is the list of published articles that have cited the current article.

  • Jianming Liu, Mats Ormo, Ann-Christin Nystrom, Josefine Claesson, and Fabrizio Giordanetto, “Transient expression, purification and characterisation of human full-length PPAR gamma 2 in HEK293 cells,” Protein Expression And Purification, vol. 89, no. 2, pp. 189–195, 2013. View at Publisher · View at Google Scholar
  • Emerson de Andrade Lima, Mariana Modesto Dantas de Andrade Lima, Claudia Diniz Lopes Marques, Angela Luzia Branco Pinto Duarte, Ivan da Rocha Pita, and Maira Galdino da Rocha Pita, “Peroxisome proliferator-activated receptor agonists (PPARs): a promising prospect in the treatment of psoriasis and psoriatic arthritis,” Anais Brasileiros de Dermatologia, vol. 88, no. 6, pp. 1029–1035, 2013. View at Publisher · View at Google Scholar
  • Parasuraman Aiya Subramani, Madhava C. Reddy, and Venkata R. Narala, “The need for physiologically relevant peroxisome proliferator-activated receptor-gamma (PPAR-γ) ligands,” Endocrine, Metabolic and Immune Disorders - Drug Targets, vol. 13, no. 2, pp. 175–183, 2013. View at Publisher · View at Google Scholar
  • Matthew B. Wright, Michele Bortolini, Moh Tadayyon, and Martin Bopst, “Minireview: Challenges and Opportunities in Development of PPAR Agonists,” Molecular Endocrinology, vol. 28, no. 11, pp. 1756–1768, 2014. View at Publisher · View at Google Scholar
  • Ekaterina A. Ivanova, Alessandro Parolari, Veronika Myasoedova, Alexandra A. Melnichenko, Yuri V. Bobryshev, and Alexander N. Orekhov, “Peroxisome proliferator-activated receptor (PPAR) gamma in cardiovascular disorders and cardiovascular surgery,” Journal of Cardiology, 2015. View at Publisher · View at Google Scholar
  • Masayoshi Kukida, Masaki Mogi, Kousei Ohshima, Hirotomo Nakaoka, Jun Iwanami, Harumi Kanno, Kana Tsukuda, Toshiyuki Chisaka, Li-Juan Min, Xiao-Li Wang, Hui-Yu Bai, Bao-Shuai Shan, Akinori Higaki, Toshifumi Yamauchi, Takafumi Okura, Jitsuo Higaki, and Masatsugu Horiuchi, “Angiotensin II Type 2 Receptor Inhibits Vascular Intimal Proliferation With Activation of PPARγ,” American Journal of Hypertension, pp. hpv168, 2015. View at Publisher · View at Google Scholar
  • Robert Andrew Brown, “The Crucial Relevance of ALA and LA as Primary Peroxisomal Beta-Oxidation Substrates, of Oxidised LA as the Primary Endogenous Activator of PPAR Gamma, and Energy Deficit as the Primary Activator of PPAR Alpha,” Omega-3 Fatty Acids, pp. 451–463, 2016. View at Publisher · View at Google Scholar
  • Brittany G. Durgin, Gary K. Owens, Jessica J. Connelly, Olga A. Cherepanova, Delphine Gomez, Themistoclis Karaoli, Gabriel F. Alencar, Joshua T. Butcher, Yu-Qing Zhou, Michelle P. Bendeck, and Brant E. Isakson, “Smooth muscle cell-specific deletion of col15α1 unexpectedly leads to impaired development of advanced atherosclerotic lesions,” American Journal of Physiology - Heart and Circulatory Physiology, vol. 312, no. 5, pp. H943–H958, 2017. View at Publisher · View at Google Scholar
  • Hanqiong Luo, Jine Liu, Qiong Ouyang, Chunxiao Xuan, Lanlan Wang, Tingting Li, and Jun Liu, “The effects of oleanolic acid on atherosclerosis in different animal models,” Acta Biochimica et Biophysica Sinica, vol. 49, no. 4, pp. 349–354, 2017. View at Publisher · View at Google Scholar
  • Rita Polito, Ersilia Nigro, Antonietta Messina, Maria L. Monaco, Vincenzo Monda, Olga Scudiero, Giuseppe Cibelli, Anna Valenzano, Elisabetta Picciocchi, Christian Zammit, Daniela Pisanelli, Marcellino Monda, Ivan R. Cincione, Aurora Daniele, and Giovanni Messina, “Adiponectin and Orexin-A as a Potential Immunity Link Between Adipose Tissue and Central Nervous System,” Frontiers in Physiology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Veeresh Kumar Sali, Atmaja Kurapati, Hannah Rachel Vasanthi, Ramesh Parjapath, and Sangeetha M. Kannan, “Hydroxycitric acid-induced activation of peroxisome proliferator-activated receptors in 3T3-L1 adipocyte cells,” Pharmacognosy Research, vol. 10, no. 3, pp. 275–281, 2018. View at Publisher · View at Google Scholar
  • Shimaa Elshazly, and Eman Soliman, “PPAR gamma agonist, pioglitazone, rescues liver damage induced by renal ischemia/reperfusion injury,” Toxicology and Applied Pharmacology, 2018. View at Publisher · View at Google Scholar
  • Yanlin Yu, Ying Zhang, Ling Nie, Chi Liu, Jiachuan Xiong, Xinlin Xu, Liang Liu, Ke Yang, Jun Gu, Yunjian Huang, Jingbo Zhang, Zhiren Zhang, Bo Zhang, Jinghong Zhao, Yong Liu, Xianjin Bi, and Ting He, “High phosphate-induced downregulation of PPARγ contributes to CKD-associated vascular calcification,” Journal of Molecular and Cellular Cardiology, vol. 114, pp. 264–275, 2018. View at Publisher · View at Google Scholar
  • Imen Bendaya, Saloua Kahla, Aouatef Riahi, Maher Kharat, Wissem Sdiri, and Ridha Oueslati, “STAT1 and STAT6 act as antagonistic regulators of PPAR? in diabetic patients with and without cardiovascular diseases,” Clinical Laboratory, vol. 64, no. 3, pp. 287–294, 2018. View at Publisher · View at Google Scholar
  • Maha M. Sabry, Amal F. Dawood, Laila A. Rashed, Seham M. Sayed, Sherif Hassan, and Sheren F. Younes, “Relation between resistin, PPAR-γ, obesity and atherosclerosis in male albino rats,” Archives of Physiology and Biochemistry, pp. 1–10, 2019. View at Publisher · View at Google Scholar